Exclusive Interview with Choice Consolidation Corp. CEO Joe Caltabiano
Joe Caltabiano stepped down from his role with Cresco Labs in March 2020. While looking for his next opportunity, he was approached by a number of public and private operators looking for executive leadership. But, nothing was quite the right fit. Eventually, he connected with people through the Senvest team about the idea of putting together a SPAC.
Choice Consolidation Corp. (NEO: CDXX.UN.U) was built with the intention of being different than a traditional SPAC, with nuances that would make it more attractive to target companies and future partners, according to Caltabiano. The Choice Consolidation CEO spoke with New Cannabis Ventures about the company’s plans to build a best-in-class MSO, second-mover advantage and his outlook on industry opportunities. The audio of the entire conversation is available at the end of this written summary.
Launching Choice Consolidation
Caltabiano comes from the mortgage lending space, where he learned a great deal about restructuring and finance. As a child, he had leukemia, which led to a life-long commitment to philanthropy related to cancer research. Through this work, he learned about how patients were using cannabis and how oncologists’ attitude toward it was evolving. By the time the Cole Memo was released and Illinois launched its medical program, he was ready to enter the cannabis business. He was among the co-founders that launched MSO Cresco Labs. Having been in the space for years, Caltabiano is eager to use the experience he has earned, drawing on both success and missteps.
Choice Consolidation has attracted other cannabis veterans, including Pete Kadens, the former CEO of GTI. Kadens is joined on the Choice Consolidation board by Lisa Gavales. Gavales has expertise in